ALKERMES reported 262.33M in Trade Debtors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US $ 68.89M 5.41M
Acorda Therapeutics ACOR:US $ 14.27M 2.28M
Amgen AMGN:US $ 5327M 250M
Biogen BIIB:US $ 2003.5M 17.9M
Biomarin Pharmaceutical BMRN:US $ 466.51M 36.36M
Bristol Myers Squibb BMY:US $ 12540M 4029M
Coherus Biosciences CHRS:US $ 115.71M 1.33M
Eli Lilly And LLY:US $ 7672.4M 133.3M
Gilead Sciences GILD:US $ 4118M 331M
Heron Therapeutics HRTX:US $ 40.3M 0.8M
Horizon Pharma HZNP:US $ 673.31M 11.2M
Intra Cellular Therapies ITCI:US $ 46.98M 14.14M
IONIS PHARMACEUT IONS:US $ 6.75M 19.37M
JAZZ PHA JAZZ:US $ 594.03M 21.64M
Marinus Pharmaceuticals MRNS:US 3M 511K
Nektar Therapeutics NKTR:US $ 10.01M 20.21M
Neurocrine Biosciences NBIX:US $ 279M 15.5M
Otsuka Holdings 4578:JP Y 396654M 34585M
Regeneron Pharmaceuticals REGN:US $ 5161.4M 322.4M
Revance Therapeutics RVNC:US $ 5.59M 1.12M
Teva Pharmaceutical Industries TEVA:US $ 4471M 218M
Vertex Pharmaceuticals VRTX:US $ 1332.9M 40.1M